Recent Progress and Future Directions of Interventional Cardiology
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 147
Special Issue Editor
Interests: coronary artery disease; coronary imaging; coronary physiology; plaque modification; valvular heart disease; aortic stenosis; renal denervation; robotically assisted percutaneous coronary interventions
Special Issue Information
Dear Colleagues,
I feel honored to serve as Guest Editor for this Special Issue aimed at covering Recent Progress and Future Directions of Interventional Cardiology.
From the first percutaneous coronary intervention (PCI) by Andreas Grüntzig in 1977 to patients undergoing robotically assisted PCI within the EVOLUTION study in 2023, interventional cardiology has seen many technical and clinical innovations. We are now well able to tailor physiology and intravascular-imaging-guided interventions to individual needs and to improve patient outcomes following evidence-based algorithms. Alain Cribier’s first transcatheter aortic valve implantation in 2002, followed by the PARTNER and EVOLUT trials, established TAVI as the standard of care in high-risk patients with severe aortic stenosis. With growing evidence of the good performance of TAVI-prostheses in intermediate and low-risk patients, advancements towards future trials such as the EXPAND II trial will show whether or not early intervention may further improve patient outcomes. With more and more devices for the treatment of tricuspid and mitral valve disease, the “winner of the race” is yet to be defined.
In the thriving and fast-paced field of interventional cardiology, I am excited to invite you to submit your original research or state-of-the-art reviews helping the scientific community to obtain a comprehensive overview on current and future directions in the interventional treatment of coronary and structural heart disease. Manuscripts should be motivated by innovation and research aimed at optimising treatment strategies, driving technical evolution and last but not least improving patient outcomes.
I am truly looking forward to your submissions.
Dr. Max Wagener
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- coronary artery disease
- structural heart disease
- PCI
- TAVI
- recent progress
- future directions
- cardiovascular outcomes
